![Bradley Williams Joins Bayer Thai as Managing Director and Leads Pharmaceuticals Division](/img/files/20240201/iqb9b1b0ed05e9be9a25d44cbf7e4ca6e4.jpg)
Bradley Williams has been appointed as Managing Director of Bayer Thai Co., Ltd and Country Division Head of Pharmaceuticals. The appointment takes effect from February 1, 2024. He will be responsible for overseeing overall development and business operations of Bayer in Thailand with a focus on our growing healthcare and agriculture sectors.
Bradley brings over 26 years of proven experience and expertise to this dual leadership position, having served in senior leadership roles throughout his career in the pharmaceutical industry. He started his career in healthcare industry in 1998 and has worked in companies such as Glaxo Wellcome, Novartis, Abbott Laboratories and AbbVie.
Joining Bayer Australia in 2020, Bradley's leadership as Business Unit Head of Specialty Medicine was instrumental in propelling forward the Ophthalmology business ensuring Bayer strengthened their market position as well as achieving significant brand growth. In 2022, Bradley broadened his scope by transitioning to Head of Portfolio, overseeing both the Ophthalmology and Cardiorenal businesses before moving to Thailand. Now, he takes on a new role as Managing Director of Bayer Thai Co., Ltd and Country Division Head of Pharmaceuticals in Thailand.
Bradley holds a Bachelor of Commerce Degree majoring in Marketing from the University of Western Sydney.